| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Recursion Pharmaceuticals, Inc. (RXRX) have been net sellers, shedding 127,408 shares worth roughly $546K on balance. In the past 30 days, 0 insiders bought and 2 sold.
Both insiders who sold still hold shares after their sales.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 6.11M | $23.98M | -50,000 | |
| CEO | 2.07M | $8.14M | - | |
| Dir | 1.48M | $5.80M | - | |
| CFO | 1.07M | $4.21M | - | |
| Other | 1.04M | $4.10M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 2, 2023 | Shafique Virani70 | Chief Business Officer | Sell10b5-1 | 42,865 | $8.73 | $374,034.45 | -22.9% | +5.7% | +0.6% | |
| May 31, 2023 | Tina Marriott Larson73 | President and COO | Sale+OE | 3,000 | $8.63 | $25,888.20 | -0.7% | -2.7% | +1.1% | |
| May 30, 2023 | Blake Borgeson68 | Director | Sell | 8,885 | $8.79 | $78,133.80 | -0.1% | -2.4% | -2.7% | |
| May 16, 2023 | Blake Borgeson68 | Director | Sell | 8,885 | $5.09 | $45,240.64 | -0.1% | +81.7% | +95.1% | |
| May 3, 2023 | Christopher Gibson71 | Chief Executive Officer | Sale+OE | 58,073 | $4.79 | $278,334.90 | - | +167.7% | +70.3% | |
| Apr 18, 2023 | Blake Borgeson68 | Director | Sell | 8,885 | $5.93 | $52,729.81 | -0.1% | +125.7% | +25.8% | |
| Apr 6, 2023 | Christopher Gibson71 | Chief Executive Officer | Sale+OE | 53,327 | $6.60 | $351,709.78 | -5.6% | +9.6% | +33.4% | |
| Apr 4, 2023 | Blake Borgeson68 | Director | Sell | 8,885 | $6.53 | $57,991.51 | -0.1% | +12.3% | +35.9% | |
| Mar 21, 2023 | Blake Borgeson68 | Director | Sell | 8,885 | $7.40 | $65,743.67 | -0.1% | +20.9% | +49.0% | |
| Mar 9, 2023 | Christopher Gibson71 | Chief Executive Officer | Sale+OE | 110,890 | $8.05 | $892,894.24 | -10.6% | +20.9% | +49.2% |